Janice Cowden: Identifying Disparities in Clinical Trial Participation is an Essential 1st Step
Janice Cowden and Marcela Mazo Canola

Janice Cowden: Identifying Disparities in Clinical Trial Participation is an Essential 1st Step

Janice Cowden, MBC Patient Advocate, shared a post by Marcela Mazo Canola, Assistant Professor at UT Health San Antonio on X:

Important work: identifying disparities in clinical trial participation is an essential 1st step.

The next challenge is developing, implementing, and measuring solutions that reduce barriers, increase access, and improve equitable participation across Cancer Clinical Trials.”

Quoting Marcela Mazo Canola’s post:

See our newest publication.”

Title: Evaluating Underrepresentation in Cancer Clinical Trial Enrollment Across Three National Cancer Institute–Designated Cancer Centers: A Retrospective Demographic Study

Authors: Guannan Gong, Jessica Liu, Mahanaz Syed, Katherine Worley, Sameer Pandya, Cristian Taborda, Lourdes Mendez, Tracy Battaglia, Travis J. Osterman, Sonya A. Reid, Marcela Mazo Canola, Sonia Lisa Creighton, Meredith Nahm Zozus, Ben Ho Park, Susan S. Padalecki, Pamela L. Kunz, Maryam Lustberg

Read The Full Article.

Janice Cowden: Identifying Disparities in Clinical Trial Participation is an Essential 1st Step

Other articles featuring Janice Cowden on OncoDaily.